Trial intelligence / Profile preview

Trizivir Induction-Maintenance Study

NCT00011895Phase 4Unknown

Sponsor
GSK
Start
Feb 2001
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of abacavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by GSK. Status: unknown.

02

Drugs

abacavir
03

Conditions

human immunodeficiency virus type 1 infection (HIV-1)

Beyond the preview

Go deeper on NCT00011895.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00011895.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call